Corrigendum to “Clinical trial designs for evaluating and exploiting cancer evolution” [Cancer Treat. Rev. 118 (2023) 101583]

The authors regret that important information was omitted from the Acknowledgments and Funding sections of the above-mentioned article. The text in these sections should read as follows:
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Corrigendum Source Type: research